Ceska, Richard
Latkovskis, Gustavs
Ezhov, Marat V.
Freiberger, Tomas
Lalic, Katarina
Mitchenko, Olena
Paragh, Gyorgy
Petrulioniene, Zaneta
Pojskic, Belma
Raslova, Katarina
Shek, Aleksandr B.
Vohnout, Branislav
Altschmiedova, Tereza
Todorovova, Veronika
Article History
First Online: 22 June 2019
Compliance with Ethical Standards
:
: Katarina Lalic, Olena Mitchenko, Zaneta Petrulioniene, Belma Pojskic, Aleksandr B. Shek, Tereza Altschmiedova, and Veronika Todorovova declare no conflicts of interest. Richard Ceska has been a consultant to Akcea Therapeutics, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Egis, MSD, NovoNordisk, Sanofi and board member of Amgen, Herbacos Recordati, Mylan, Novartis, Novatin, Pfizer, Promed, Roche, Sanofi, Servier, and he is paid speaker to Akcea Therapeutics, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Egis, Herbacos Recordati, MSD, Mylan, Novartis, Novatin, NovoNordisk, Pfizer, Promed, Roche, Sanofi, and Servier. Richard Ceska has received honoraria from Amgen, Esperion, Kowa, Regeneron, and Sanofi (PI, NC), and he reports grant support from IAS, Pfizer, and Teva. Gustavs Latkovskis declares speaker fees, honoraria, consultancy, and board membership to Astra Zeneca, Bayer, Berlin Chemie AG, Boehringer-Ingelheim, Servier, Mylan, Sanofi Aventis, Amgen, Novo-Nordisk, Krka Pharma, Roche Diagnostics, and Novartis, and he reports grant support from Latvian Council of Science. Marat V. Ezhov is a paid speaker from Amgen, Alexion, AZ, Berlin Chemie, Egis, KRKA, NovoNordisk, Pfizer, Recordati, and Sanofi, and he also reports travel fees. Tomas Freiberger has received honoraria from Amgen and Sanofi and grants from AZV, Ministry of Health, and CR for his institution, and he has been a consultant to Sanofi. Gyorgy Paragh has been a consultant and he declares travel fees from Richter Gedeon, fees for board membership from Sanofi Aventis and Amgen, and honoraria, and he is also a paid speaker. Katarina Raslova has received financial support from Sanofi, Amgen, NovoNordisk, and Mylan for consultancy, board membership, honoraria, and travel fees, and she also reports grant support from Sanofi for her institution. Branislav Vohnout has been a consultant to Sanofi, and he has received honoraria from Amgen, Sanofi, Mylan, Krka, and NovoNordisk. Branislav Vohnout has also received support from Amgen, Sanofi for board membership, and from Sanofi, Mylan, Amgen for traveling, and he is a paid speaker by Sanofi and Mylan.
: The leaders in all countries involved in the ScreenPro FH project got acquainted with ethical statements of the country, and the project complies with ethical criteria of a non-interventional retrospective study in all participating countries.